Bespoke Extracts, Inc.
Bespoke Extracts, Inc. is a U.S.-based cannabis products company that operates through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC. The company runs a marijuana-infused products manufacturing facility in Colorado and has shifted its focus from CBD offerings toward regulated cannabis markets in the United States. Its reported operating activity centers on producing and selling pre-rolled joints and providing joint production and processing services to licensed dispensaries and third parties. The business remains small and development-stage in nature, with management emphasizing expansion rather than a mature, diversified operating footprint.
Fiscal year 2024 · change from previous year
Development 2019–2024
Business
Share of revenueFinished cannabis products sold under the company's own product lines, including pre-rolled joints.
Third-party joint production and related manufacturing services performed for other cannabis businesses.
Processing work for third parties that use the company's Colorado facility and operational capabilities.
Customers
The company's direct customers appear to be licensed dispensaries in Colorado that purchase pre-rolled joints for resale to end consumers. It also serves third-party cannabis businesses that outsource joint production and processing work to Bespoke Extracts Colorado. These customers buy for access to manufacturing capacity, product supply, and regulated cannabis production expertise rather than for broad national distribution. The customer base is concentrated in a regulated, state-level market, which makes licensing status and compliance critical to demand. Because the company is still small, a limited number of commercial relationships likely have a meaningful impact on revenue.
Buy pre-rolled joints for retail resale to adult-use or medical consumers in the Colorado cannabis market.
Outsource joint production and related manufacturing to access capacity and reduce fixed operating costs.
Use the company's facility for processing services tied to cannabis product preparation and handling.
Strategy
Management's stated strategy is to expand beyond CBD offerings and focus on regulated cannabis markets in the United States. Near term, the company is trying to grow sales through pre-rolled joints, new product introductions, and increased third-party production and processing work. The business also appears to be building around the WonderLeaf asset purchase, which added a marijuana-infused products license, inventory, and extraction equipment. A key strategic issue is funding, because the company has not generated positive operating cash flow and must raise additional capital to continue and expand operations. Execution depends on maintaining regulatory compliance, scaling production, and securing enough capital to support working capital and growth.
The company is repositioning away from CBD toward higher-opportunity regulated cannabis markets.
Higher throughput in joints and processing services is the main path to revenue growth in the current model.
The company needs external capital to fund operations because it has not generated positive operating cash flow.
Geography
Bespoke Extracts' operating footprint is centered in Colorado, where its manufacturing facility and reported sales activity are located. The company has stated that it intends to expand its focus to regulated cannabis markets in the United States, but the disclosed revenue base remains tied to Colorado. This creates a concentrated exposure to one state market, including local licensing, regulatory, and competitive conditions. Because cannabis is regulated at the state level, geography is not just a sales issue but also a licensing and operating constraint. No country-level revenue breakdown was disclosed in the excerpts provided.
Risks
The company faces substantial going-concern and liquidity risk because it has not generated positive operating cash flow and has a working capital deficit. Its reliance on equity and convertible debt financing means operations can be constrained if capital markets are unavailable or expensive. Business risk is also elevated because revenue is concentrated in a single regulated cannabis market, where licensing, compliance, and local competition can change quickly. The company itself highlights potential quarterly volatility, rapid market changes, and the possibility that revenues may not cover operating costs. More generally, cannabis operators face regulatory uncertainty, product demand swings, and supply-chain or manufacturing disruptions that can affect both sales and margins.
The company has negative operating cash flow, a working capital deficit, and no committed financing sources.
Exposure: Ability to continue and expand operations
Operations have been funded primarily through equity and convertible debt, which may not be available on acceptable terms.
Exposure: Liquidity and growth funding
Sales are concentrated in licensed dispensaries in Colorado, making results sensitive to one state market.
Exposure: Revenue stability
The business depends on state-level cannabis licensing and compliance, which can change or be restricted.
Exposure: Operating permissions and customer access
Management explicitly notes potential fluctuation in quarterly results and rapid market changes.
Exposure: Comparability and forecasting
Accounting
Judgemental itemsSales of pre-rolled joints and third-party services may be recognized at different points depending on delivery or completion.
Impact: Affects quarterly revenue timing and comparability
Management estimates credit losses based on customer quality and market conditions.
Impact: Can materially affect reported earnings and cash conversion
Cannabis inventory is measured at the lower of cost or net realizable value.
Impact: Can create write-downs if demand weakens or products become obsolete
The company carries a full valuation allowance because it does not yet expect to realize tax benefits.
Impact: Prevents recognition of tax assets until profitability is sustained
Similar listed companies
Publicly listed companies with a comparable business focus.
CordovaCann Corp.
LVRLF · Services-Amusement & Recreation Services
Charlie's Holdings, Inc.
CHUC · Medicinal Chemicals & Botanical Products
Bio Essence Corp
BIOE · Pharmaceutical Preparations
Bio Essence Corp is a California-based holding company whose operating history has centered on health supplements and OEM manufacturing/distribution services.
Cero Therapeutics Holdings, Inc.
CEROW · Biological Products, (No Diagnostic Substances)
CV Sciences, Inc.
CVSI · Pharmaceutical Preparations
Cannabis Bioscience International Holdings, Inc.
CBIH · Services-Commercial Physical & Biological Research
Last updated: 11/08/2026